Supplementary Table 2 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib
收藏Figshare2021-02-01 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Table_2_from_AZD0364_Is_a_Potent_and_Selective_ERK1_2_Inhibitor_That_Enhances_Antitumor_Activity_in_i_KRAS_i_-Mutant_Tumor_Models_when_Combined_with_the_MEK_Inhibitor_Selumetinib/22521538
下载链接
链接失效反馈官方服务：
资源简介：
Response of 747 cell lines to treatment with AZD0364 for 72 hours.
创建时间：
2021-02-01
